
26/12/2024
Good evening everyone
Many of you, who have attended a gastroenterology clinic or endoscopy, may have heard about a bacteria a Helicobacter pylori. Your doctor may have told you that this bacteria may be responsible for quite a few symptoms or gastric ailments. So what is actually H pylori and what are its clinical implications? I shall make an attempt to give an overview.
Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped bacteria that colonizes the gastric mucosa (specifically this is the microbiological nature of this organism)
It is one of the most common infections worldwide and has significant clinical implications, ranging from benign to severe gastrointestinal diseases.
Clinical Implications of H. pylori Infection -
1. Asymptomatic Carrier State - Most individuals infected with H. pylori remain asymptomatic, but they may serve as reservoirs for transmission.
2. Gastritis
a . Chronic Gastritis: H. pylori induces chronic inflammation of the gastric mucosa, which can be mild, moderate, or severe.
b. Symptoms: Epigastric pain, nausea, and dyspepsia.
3. Peptic Ulcer Disease (PUD) - H. pylori is a major cause of:
a. Gastric ulcers.
b. Duodenal ulcers (most common).
Mechanism - It disrupts the mucosal barrier by producing urease, which neutralizes stomach acid and leads to increased acid secretion and inflammation.
Symptoms - Epigastric pain, often relieved by food in duodenal ulcers, or worsened after meals in gastric ulcers.
4. Gastric Cancer
a. Adenocarcinoma: H. pylori is classified as a Group 1 carcinogen by WHO.
Mechanism: Chronic inflammation leads to atrophic gastritis, intestinal metaplasia, dysplasia, and eventually cancer.
Risk Factors: Long-standing infection, high salt diet, smoking, and genetic predisposition.
b. MALT Lymphoma: Low-grade mucosa-associated lymphoid tissue (MALT) lymphoma is directly linked to H. pylori. Eradication of H. pylori can induce remission in early stages.
5. Non-Ulcer Dyspepsia - H. pylori is associated with functional dyspepsia (symptoms without an identifiable ulcer or structural cause). Symptoms are epigastric (upper abdominal) discomfort, bloating, nausea.
6. Iron Deficiency Anemia (IDA) - Chronic H. pylori infection may impair iron absorption or cause occult gastrointestinal bleeding, contributing to unexplained IDA.
Diagnosis of H. pylori
1. Non-Invasive Tests:
Urea Breath Test: Measures labeled CO₂ in exhaled breath.
Stool Antigen Test: Detects H. pylori antigens in f***s.
Serology: Detects antibodies but cannot differentiate active from past infection.
2. Invasive Tests (via endoscopy):
Rapid Urease Test (CLO test or RUT): Detects urease activity in biopsy samples.
Histology: Biopsy specimens stained to visualize bacteria.
Culture: For antibiotic susceptibility testing (rarely performed).
Treatment of H. pylori
First-line Therapy: Triple or quadruple therapy.
Triple Therapy (14 days): PPI (e.g., omeprazole) + Clarithromycin + Amoxicillin/Metronidazole. (Most commonly used)
Quadruple Therapy (if resistance or prior treatment failure): PPI + Bismuth subsalicylate + Tetracycline + Metronidazole.
Tailor treatment based on regional antibiotic resistance patterns.
Prevention
• Improved sanitation and hygiene.
• Avoidance of contaminated food and water.
• Screening and treatment in high-risk populations (e.g., family history of gastric cancer).
Early detection and eradication of H. pylori can prevent progression to serious diseases like peptic ulcer and gastric cancer, improving patient outcomes significantly.
Image - no copyright infringement intended